BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3548131)

  • 1. [Immunohistochemical estimation of the proliferative action of breast and large intestine carcinomas].
    Horny HP; Horst HA
    Verh Dtsch Ges Pathol; 1986; 70():262-8. PubMed ID: 3548131
    [No Abstract]   [Full Text] [Related]  

  • 2. [The immunohistochemical localization of CA 15-3 in human breasts and their tumors].
    Ishikawa T; Tanaka Y; Sugihara K; Hatano M; Kaneko A; Motoji K; Nasu M; Okayasu I; Sato T; Inaba N
    Gan No Rinsho; 1988 Mar; 34(3):277-82. PubMed ID: 2833635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological evaluation of patients with adenocarcinoma of the large bowel on immunotherapy.
    Wilkins SA; Olkowski ZL
    Am J Proctol; 1977 Jun; 28(3):27-34. PubMed ID: 869020
    [No Abstract]   [Full Text] [Related]  

  • 4. New test for cancer.
    Br Med J; 1971 Jul; 3(5767):134. PubMed ID: 5557860
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunochemical study of the antigens isolated from a gastric adenocarcinoma].
    Pavlenko AF; Kurika AV; Moroz SV; Ovodov IuS; Maslova MG
    Vopr Onkol; 1982; 28(4):14-6. PubMed ID: 6806977
    [No Abstract]   [Full Text] [Related]  

  • 6. [Assessment of the prognosis of breast cancer. Determination of the growth fraction using monoclonal antibody Ki-67].
    Lellé RJ
    Fortschr Med; 1989 Jun; 107(17):380-1. PubMed ID: 2663680
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological markers of precancer of the large intestine].
    Zagrebin VM
    Arkh Patol; 1995; 57(4):89-92. PubMed ID: 8526767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma.
    Papsidero LD; Croghan GA; O'Connell MJ; Valenzuela LA; Nemoto T; Chu TM
    Cancer Res; 1983 Apr; 43(4):1741-7. PubMed ID: 6339043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of carcinoembryonic antigen, epithelial membrane antigen, and secretory immunoglobulin system in the large bowel adenoma-carcinoma sequence.
    Lapertosa G; Baracchini P; Fulcheri E; Tanzi R
    Cancer Detect Prev; 1986; 9(5-6):469-76. PubMed ID: 3536092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HLA antigens in breast cancer.
    Horan Hand P; Colcher D; Wunderlich D; Nuti M; Teramoto YA; Schlom J
    Prog Clin Biol Res; 1983; 133():115-24. PubMed ID: 6194534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of leukocyte sensitization to tumor and embryonic tissue antigens in cancer of the large intestine].
    Novikov DK; Shmakov AP
    Vopr Onkol; 1981; 27(8):40-5. PubMed ID: 6269300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor immunity in patients with carcinoma of the large intestine.
    Harlozińska A; Lange A; Woźniewski A; Kasprzak A; Zólczyńska-Kasperowicz B; Szymańska J
    Arch Immunol Ther Exp (Warsz); 1974; 22(4):541-9. PubMed ID: 4424958
    [No Abstract]   [Full Text] [Related]  

  • 14. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
    Hand PH; Nuti M; Colcher D; Schlom J
    Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of monoclonal antibodies in the detection of blood group antigens A and B in the mucosa of the large intestine].
    Vanák J; Ehrmann J; Drímalová D; Nĕmec M; Viklický V; Wisniewski K; Gregar I
    Cas Lek Cesk; 1988 Mar; 127(12):364-7. PubMed ID: 3365736
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of immunohistochemical probes in the study of benign and malignant breast disease.
    Gusterson BA; Warburton MJ; Monaghan P; Foster C; Edwards P; Kraft N; Smith C; Mitchell D; Rudland PS; Neville AM
    Behring Inst Mitt; 1984 May; (74):39-48. PubMed ID: 6383328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and histochemical characteristics of target antigen detected by monoclonal antibody HBCA-12 against a membrane component of human mammary carcinoma cell line.
    Kovarík J; Chorváth B; Duraj J; Bártek J; Rejthar A; Lauerová L; Babusíková O
    Neoplasma; 1984; 31(6):625-9. PubMed ID: 6521796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomorphological study of 1,2-dimethylhydrazine-induced carcinomas of the large intestine in rats using monoclonal antibodies to intermediate filament proteins].
    Krutovskikh VA; Troianovskiĭ SM
    Biull Eksp Biol Med; 1985 Aug; 100(8):240-1. PubMed ID: 3896343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to detect breast cancer cells in bone marrow.
    Diel IJ; Kaufmann M; Costa SD; Bastert G
    Important Adv Oncol; 1994; ():143-64. PubMed ID: 8206487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.